Sezaby Injection Dosage
Generic name: PHENOBARBITAL SODIUM 100mg
Dosage form: injection
Drug classes: Barbiturate anticonvulsants, Barbiturates
Medically reviewed by Drugs.com. Last updated on Sep 26, 2024.
Recommended Dosage and Administration
The recommended dosage of SEZABY in neonates consists of a loading dose(s) followed by maintenance dosage (see Table 1). Administer SEZABY by intravenous infusion (over 15 minutes) into a large peripheral vein to avoid local tissue toxicity. SEZABY is for intravenous use only.
Table 1: Recommended Dosage of SEZABY for Neonatal Seizures
Loading Dose (maximum total loading dose is 40 mg/kg) |
||
First loading dose |
20 mg/kg |
|
Second loading dose (If clinically indicated)1 |
Preterm Infants |
10 mg/kg or 20 mg/kg |
Term Infants |
20 mg/kg |
|
Maintenance Dosage (total daily dose is 4.5 mg/kg/day and the total duration is up to 5 days) Initiate 8 to 12 hours after first loading dose |
||
Option 1 |
1.5 mg/kg every 8 hours |
|
Option 2 |
2.25 mg/kg every 12 hours |
1If seizures persist or recur any time 15 minutes after completion of the initial loading dose, administer a second loading dose. (Administer the second loading dose no sooner than 15 minutes after completion of the first loading dose.)
Reconstitution and Additional Administration Instructions
- Determine the number of vials to be reconstituted based on the patient’s weight and recommended dose.
- Aseptically reconstitute the lyophilized powder in the vial using 10 mL of 0.9% Sodium Chloride Injection, USP.
- Swirl the vial gently until contents are completely dissolved.
- The reconstituted solution contains 100 mg per 10 mL (10 mg/mL) of phenobarbital sodium.
- Inspect the vial visually for particulate matter and discoloration prior to administration (the reconstituted solution is clear, colorless, and free from visible particulate matter).
- Discard the reconstituted solution if it is discolored or contains foreign particles.
- Withdraw the appropriate volume from the reconstituted vial for intravenous infusion and administer immediately.
- Discard any unused portion of the reconstituted solution left in the vial.
Storage of Reconstituted Solution
If the reconstituted solution is not administered immediately, place the vial back in the original carton to protect it from light and store at either room temperature at 20°C to 25°C (68°F to 77°F) for a maximum of 8 hours or in the refrigerator at 2°C to 8°C (36°F to 46°F) for a maximum of 24 hours. Discard any unused portion of the reconstituted solution after the recommended storage duration.
More about Sezaby (phenobarbital)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- During pregnancy
- FDA approval history
- Drug class: barbiturate anticonvulsants
- Breastfeeding
Patient resources
Other brands
Professional resources
- Sezaby Injection prescribing information
- PHENobarbital, PHENobarbital Sodium (Systemic) (Sedative) (AHFS Monograph)
Related treatment guides
See also:
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Carbamazepine
Carbamazepine is used to treat epileptic seizures and nerve pain such as trigeminal neuralgia ...
Diazepam
Diazepam is used to treat anxiety disorders, alcohol withdrawal symptoms, or muscle spasms. Learn ...
Levetiracetam
Levetiracetam systemic is used for bipolar disorder, epilepsy, hyperekplexia, neuralgia, new daily ...
Topiramate
Topiramate systemic is used for bipolar disorder, borderline personality disorder, bulimia ...
Pregabalin
Pregabalin may be used to treat certain types of pain and used in combination with other ...
Clonazepam
Clonazepam is used to treat seizures and panic disorder. Learn about side effects, interactions and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.